June 26 (THEWILL) — Shareholders of Neimeth International Pharmaceuticals Plc have approved an additional N30 billion capital raise, increasing the company’s total fundraising mandate to N50 billion to support its expansion plans and strengthen its financial position. The approval was granted unanimously at the company’s 67th Annual General Meeting (AGM), held virtually on June 25,
Related Articles
Don't miss out on breaking stories and in-depth articles.